A groundbreaking trial is offering hope to people battling severe alcohol and opioid addiction. Scientists at Addenbrooke’s Hospital in Cambridge and King’s College Hospital in London are testing a new technique called deep brain stimulation (DBS), often referred to as a “brain pacemaker.”
DBS involves implanting tiny electrodes into specific areas of the brain to help regulate activity and control cravings. This neurosurgical procedure has already proven effective for neurological conditions like Parkinson’s disease and obsessive-compulsive disorder. Now, researchers want to see if it can help people struggling with addiction.
According to the University of Cambridge, DBS acts as a “brain pacemaker,” stabilising abnormal brain activity linked to compulsive behaviours. The Brain Pacemaker Addiction Control to End Relapse study (Brain-PACER) is currently recruiting participants to assess its effectiveness in reducing cravings and preventing relapse.
Many people with addiction can recover with support and treatment. However, for those with severe and treatment-resistant addiction, existing methods often fall short. Professor Valerie Voon from the University of Cambridge’s Department of Psychiatry explains:
We want to see if deep brain stimulation can transform the lives of those who have not responded to traditional treatments.
Dr David Okai from King’s College London highlights the benefits of DBS, describing it as “safe, reversible, and adjustable,” offering a personalised approach to treatment. Researchers hope this method will provide a much-needed lifeline for individuals struggling with severe addiction.
A groundbreaking trial is offering hope to people battling severe alcohol and opioid addiction. Scientists at Addenbrooke’s Hospital in Cambridge and King’s College Hospital in London are testing a new technique called deep brain stimulation (DBS), often referred to as a “brain pacemaker.”
Neuralink and the Future of Brain Technology
The concept of brain implants has gained mainstream attention due to Elon Musk‘s Neuralink. Neuralink aims to develop advanced brain-computer interfaces (BCIs) to help people with neurological disorders, enhance cognitive abilities, and even merge human consciousness with artificial intelligence. While Neuralink’s focus is broader, both technologies share the goal of improving brain function through electrical stimulation.
With DBS proving effective for addiction treatment and Neuralink pushing the boundaries of brain-machine integration, the future of neurotechnology looks promising. These innovations could open the door to revolutionary treatments for mental health and neurological conditions.
How to Get Involved
The Brain-PACER study is supported by the Medical Research Council and UK Research and Innovation. If you or someone you know is interested in participating, more details on eligibility and enrolment can be found on the Brain-PACER website.
This pioneering trial could revolutionise addiction treatment, offering new possibilities for those in need of long-term solutions.
